The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 20, 2016

Filed:

Sep. 05, 2003
Applicants:

David Baltimore, Pasadena, CA (US);

Matthew Porteus, Dallas, TX (US);

Inventors:

David Baltimore, Pasadena, CA (US);

Matthew Porteus, Dallas, TX (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/00 (2006.01); C12N 5/10 (2006.01); A61K 48/00 (2006.01); C12N 15/90 (2006.01); C12N 9/22 (2006.01);
U.S. Cl.
CPC ...
C12N 15/907 (2013.01); C12N 9/22 (2013.01); A61K 48/00 (2013.01); C07K 2319/00 (2013.01); C07K 2319/09 (2013.01); C07K 2319/43 (2013.01); C07K 2319/81 (2013.01); C12N 2800/80 (2013.01); C12N 2830/00 (2013.01); C12N 2830/15 (2013.01); C12N 2830/48 (2013.01); C12N 2830/60 (2013.01); C12N 2830/90 (2013.01); C12N 2840/203 (2013.01);
Abstract

Gene targeting is a technique to introduce genetic change into one or more specific locations in the genome of a cell. For example, gene targeting can introduce genetic change by modifying, repairing, attenuating or inactivating a target gene or other chromosomal DNA. In one aspect, this disclosure relates to methods and compositions for gene targeting with high efficiency in a cell. This disclosure also relates to methods of treating or preventing a genetic disease in an individual in need thereof. Further disclosed are chimeric nucleases and vectors encoding chimeric nucleases.


Find Patent Forward Citations

Loading…